Home LiteratureArticle Details
PMID: 10613725 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway.

Hepatology (Baltimore, Md.) ·Vol. 31 ·No. 1 ·2000-01-00 ·Pages 35-42

Selzner M, Clavien PA

Abstract

Hepatic resection or transplantation in patients with fatty liver is associated with increased morbidity and mortality. The regenerative capacity of fatty livers after major tissue loss is unknown. Interleukin 6 (IL-6) is a potent inducer of hepatic regeneration in normal and ischemic livers. Therefore, we studied hepatic regeneration at day 1, day 2, and day 4 in a model of 70% hepatectomy in obese and lean Zucker rats, and obese Zucker rats pretreated with recombinant interleukin 6 (rIL-6). The mitotic cycle in hepatocytes was investigated by 4 different markers of regeneration representing distinct phases of mitosis (proliferating cell nuclear antigen [PCNA] = G(1) phase, bromodeoxy uridine [BrdU] = S phase, mitotic index, and regenerated liver weight = M phase). Obese Zucker rats had significantly decreased regenerative capacity compared with lean Zucker rats (PCNA, BrdU, mitotic index, regenerated liver weight) at days 1 and 2 after surgery. Four days after resection fatty animals showed an increase in the mitotic index indicating a delay of regeneration in steatotic livers. Animal survival after 70% hepatectomy was significantly decreased in obese rats compared with lean animals. Pretreatment of obese animals with rIL-6 normalized PCNA expression (G(1) phase) in steatotic hepatocytes but failed to increase DNA synthesis (BrdU, S phase), mitosis (mitotic index and regenerated liver weight, M phase), and animal survival. These results indicate major impairment of hepatic regeneration in steatotic livers. Two different blockages of regeneration must be present, one rIL-6 sensitive, at the level of IL-6 or upstream, and a second, rIL-6 resistant, at the level of G(1)/S-phase transition.

MeSH Terms
Animals Apoptosis Cell Cycle Fatty Liver/pathology,physiopathology,surgery G1 Phase Hepatectomy Injections, Intraperitoneal Interleukin-6/pharmacology Liver Regeneration Necrosis Obesity/complications Proliferating Cell Nuclear Antigen/analysis Rats Rats, Zucker Recombinant Proteins/pharmacology S Phase
Chemicals
Interleukin-6 Proliferating Cell Nuclear Antigen Recombinant Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Selzner M
Laboratory of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Clavien P A
Article Info
Journal
Hepatology (Baltimore, Md.)
Abbr.
Hepatology
ISSN
0270-9139
Published
2000-01-00
Pages
35-42
Language
English
Region
United States
NLM ID
8302946
Subset
IM
Grants
NIDDK NIH HHS · DK54048-01A1 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com